- Home
- PLX vs BNC Comparison
PLX vs BNC Comparison
Compare PLX & BNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PLX | BNC |
|---|---|---|
| Founded | 1993 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 204.9M | 215.8M |
| IPO Year | 1998 | N/A |
Fundamental Metrics
Financial Performance| Metric | PLX | BNC |
|---|---|---|
| Price | $1.71 | $7.54 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $12.00 | N/A |
| AVG Volume (30 Days) | 570.7K | ★ 684.2K |
| Earning Date | 11-13-2025 | 12-23-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.07 | N/A |
| Revenue | ★ $61,840,000.00 | $4,027,431.00 |
| Revenue This Year | $14.53 | N/A |
| Revenue Next Year | $75.77 | N/A |
| P/E Ratio | $24.25 | ★ N/A |
| Revenue Growth | ★ 35.41 | 27.46 |
| 52 Week Low | $1.32 | $4.65 |
| 52 Week High | $3.10 | $82.88 |
Technical Indicators
Market Signals| Indicator | PLX | BNC |
|---|---|---|
| Relative Strength Index (RSI) | 35.14 | 57.91 |
| Support Level | $1.71 | $5.01 |
| Resistance Level | $1.86 | $7.21 |
| Average True Range (ATR) | 0.12 | 0.53 |
| MACD | -0.01 | 0.43 |
| Stochastic Oscillator | 16.67 | 98.46 |
Price Performance
Historical ComparisonAbout PLX Protalix BioTherapeutics Inc. (DE)
Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis. The company's primary sources of revenue include its sales of BioManguinhos alfataliglicerase in Brazil and of drug substances to Pfizer under its Amended Pfizer Agreement. The company's pipeline consists of ELFABRIO, Uricase, and Long Acting DNase I.
About BNC CEA Industries Inc. Common Stock
CEA Industries Inc through its subsidiary is focused on selling environmental control and other technologies and services to the Controlled Environment Agriculture ("CEA") industry. The company provides integrated mechanical, electrical, and plumbing ("MEP") engineering design, proprietary and curated environmental control equipment, and automation offerings that serve the CEA industry. The Company has one operating segment that is dedicated to the manufacture and sale of its products.